Introduction
Stanley Qi (Lei Qi, born August 17, 1983) is an assistant professor in the Department of Bioengineering, and the Department of Chemical and Systems Biology at Stanford University. Qi led the development of the first catalytically dead Cas9 lacking endonuclease activity (dCas9), which is the basis for CRISPR interference (CRISPRi). His laboratory subsequently developed CRISPR-Genome Organization (CRISPR-GO).
Qi is a co-inventor of the University of California patent on the CRISPR gene-editing technology.
Early life and education
Qi obtained B.S. in physics and math from Tsinghua University, China, Master in physics from UC Berkeley, and PhD in bioengineering from UC Berkeley. During his PhD work at Berkeley, he studied synthetic biology with Adam Arkin, and was the first to exploreengineering the CRISPR for targeted gene editing and gene regulation with Jennifer Doudna. After PhD, he performed independent research work as a faculty fellow at UCSF. He joined Stanford faculty in 2014.
Award
Stanley has won awards, including NIH Director's Early Independence Award, Pew Biomedical Scholar, and Alfred. P. Sloan Fellowship.